| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Min Ho Song, Jimeen Yoo, Jae Gyun Oh, Hyun Kook, Woo Jin Park, Dongtak Jeon. Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in Frontiers in cardiovascular medicine. vol 9. 2022-05-13. PMID:35557546. |
patients with dmd initially experience muscle weakness in their limbs during adolescence. |
2022-05-13 |
2023-08-13 |
Not clear |
| Eduardo L De Vito, Sergio G Monteiro, Santiago C Arc. Compartmental nutritional status and respiratory muscle function assessment in subjects with neuromuscular diseases. Medicina. vol 82. issue 2. 2022-04-13. PMID:35417383. |
the objective was to establish correlations between compartmental nutritional variables and respiratory variables to identify respiratory muscle weakness determinants of patients with amyotrophic lateral sclerosis (als) and duchenne muscular dystrophy (dmd). |
2022-04-13 |
2023-08-13 |
human |
| Angelika Svetlove, Jonas Albers, Swen Hülsmann, Marietta Andrea Markus, Jana Zschüntzsch, Frauke Alves, Christian Dulli. Non-Invasive Optical Motion Tracking Allows Monitoring of Respiratory Dynamics in Dystrophin-Deficient Mice. Cells. vol 11. issue 5. 2022-03-10. PMID:35269540. |
duchenne muscular dystrophy (dmd) is the most common x-chromosomal inherited dystrophinopathy which leads to progressive muscle weakness and a premature death due to cardiorespiratory dysfunction. |
2022-03-10 |
2023-08-13 |
mouse |
| Amaia Paredes-Redondo, Peter Harley, Eleni Maniati, David Ryan, Sandra Louzada, Jinhong Meng, Anna Kowala, Beiyuan Fu, Fengtang Yang, Pentao Liu, Silvia Marino, Olivier Pourquié, Francesco Muntoni, Jun Wang, Ivo Lieberam, Yung-Yao Li. Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections. Science advances. vol 7. issue 37. 2022-02-10. PMID:34516770. |
duchenne muscular dystrophy (dmd) is caused by dystrophin gene mutations leading to skeletal muscle weakness and wasting. |
2022-02-10 |
2023-08-16 |
human |
| Arianna Manini, Elena Abati, Andi Nuredini, Stefania Corti, Giacomo Pietro Com. Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence. Frontiers in neurology. vol 12. 2022-01-31. PMID:35095747. |
duchenne muscular dystrophy (dmd) is an x-linked recessive, infancy-onset neuromuscular disorder characterized by progressive muscle weakness and atrophy, leading to delay of motor milestones, loss of autonomous ambulation, respiratory failure, cardiomyopathy, and premature death. |
2022-01-31 |
2023-08-13 |
Not clear |
| Pirkka-Pekka Laurila, Peiling Luan, Martin Wohlwend, Nadège Zanou, Barbara Crisol, Tanes Imamura de Lima, Ludger J E Goeminne, Hector Gallart-Ayala, Minho Shong, Julijana Ivanisevic, Nicolas Place, Johan Auwer. Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy. Science advances. vol 8. issue 4. 2022-01-28. PMID:35089797. |
duchenne muscular dystrophy (dmd), the most common muscular dystrophy, is a severe muscle disorder, causing muscle weakness, loss of independence, and premature death. |
2022-01-28 |
2023-08-13 |
Not clear |
| Amir Dori, Michela Guglieri, Marianna Scutifero, Luigia Passamano, Antonio Trabacca, Luisa Politan. Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology. vol 40. issue 4. 2022-01-20. PMID:35047755. |
although no causative cure there is for dmd, therapies are available to slow the decline of muscle weakness and delay the onset of heart and respiratory involvement. |
2022-01-20 |
2023-08-13 |
Not clear |
| Kenji Rowel Q Lim, Md Nur Ahad Shah, Stanley Woo, Harry Wilton-Clark, Pavel Zhabyeyev, Faqi Wang, Rika Maruyama, Gavin Y Oudit, Toshifumi Yokot. Natural History of a Mouse Model Overexpressing the Dp71 Dystrophin Isoform. International journal of molecular sciences. vol 22. issue 23. 2021-12-10. PMID:34884423. |
loss of dystrophin as in duchenne muscular dystrophy (dmd) causes progressive skeletal muscle weakness and cardiac dysfunction. |
2021-12-10 |
2023-08-13 |
mouse |
| Luana Tripodi, Davide Molinaro, Andrea Farini, Gendenver Cadiao, Chiara Villa, Yvan Torrent. Flavonoids and Omega3 Prevent Muscle and Cardiac Damage in Duchenne Muscular Dystrophy Animal Model. Cells. vol 10. issue 11. 2021-12-08. PMID:34831140. |
therefore, we propose flavomega β as food supplement suitable for preventing muscle weakness, delaying inflammatory milieu, and sustaining physical health in patients affected from dmd. |
2021-12-08 |
2023-08-13 |
mouse |
| Shelagh M Szabo, Katherine L Gooch, Alexis T Mickle, Renna M Salhany, Anne M Connoll. The impact of genotype on outcomes in individuals with Duchenne muscular dystrophy: A systematic review. Muscle & nerve. 2021-12-08. PMID:34878187. |
duchenne muscular dystrophy (dmd) is associated with progressive muscle weakness, loss of ambulation (loa), and early mortality. |
2021-12-08 |
2023-08-13 |
Not clear |
| Ahmed Razeq, Samiya Ahma. Early Identification of DMD in the Setting of West Syndrome. Child neurology open. vol 8. 2021-12-07. PMID:34869784. |
dmd is a genetic disorder with x-linked recessive inheritance pattern characterized by a severe muscular phenotype with progressive muscle weakness and atrophy due to pathogenic variations within the dmd gene. |
2021-12-07 |
2023-08-13 |
Not clear |
| Luis Garegnani, Martin Hyland, Pablo Roson Rodriguez, Camila Micaela E Escobar Liquitay, Juan Va Franc. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. The Cochrane database of systematic reviews. vol 11. 2021-12-06. PMID:34748221. |
duchenne muscular dystrophy (dmd) is an x-linked recessive disorder characterised by progressive muscle weakness beginning in early childhood. respiratory failure and weak cough develop in all patients as a consequence of muscle weakness leading to a risk of atelectasis, pneumonia, or the need for ventilatory support. there is no curative treatment for dmd. |
2021-12-06 |
2023-08-13 |
Not clear |
| Luis Garegnani, Martin Hyland, Pablo Roson Rodriguez, Camila Micaela E Escobar Liquitay, Juan Va Franc. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. The Cochrane database of systematic reviews. vol 11. 2021-12-06. PMID:34748221. |
corticosteroids are the only pharmacological intervention proven to delay the onset and progression of muscle weakness and thus respiratory decline in dmd. |
2021-12-06 |
2023-08-13 |
Not clear |
| Luis Garegnani, Martin Hyland, Pablo Roson Rodriguez, Camila Micaela Escobar Liquitay, Juan Va Franc. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. The Cochrane database of systematic reviews. vol 12. 2021-12-04. PMID:34850383. |
duchenne muscular dystrophy (dmd) is an x-linked recessive disorder characterised by progressive muscle weakness beginning in early childhood. respiratory failure and weak cough develop in all patients as a consequence of muscle weakness leading to a risk of atelectasis, pneumonia, or the need for ventilatory support. there is no curative treatment for dmd. |
2021-12-04 |
2023-08-13 |
Not clear |
| Luis Garegnani, Martin Hyland, Pablo Roson Rodriguez, Camila Micaela Escobar Liquitay, Juan Va Franc. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. The Cochrane database of systematic reviews. vol 12. 2021-12-04. PMID:34850383. |
corticosteroids are the only pharmacological intervention proven to delay the onset and progression of muscle weakness and thus respiratory decline in dmd. |
2021-12-04 |
2023-08-13 |
Not clear |
| Susan Sienko, Cathleen E Buckon, Anita Bagley, Loretta Staudt, Eileen Fowler, Kent Heberer, Mitell Sison-Williamson, Craig McDonald, Michael D Sussma. Longitudinal changes in energy cost during walking in boys with Duchenne Muscular Dystrophy (DMD). Gait & posture. vol 90. 2021-12-01. PMID:34564002. |
in boys with dmd, muscle weakness progresses in a proximal to distal pattern, leading to compensatory gait strategies, including hyperlordosis and equinus, that increase energy cost and accelerate the loss of walking capacity. |
2021-12-01 |
2023-08-13 |
Not clear |
| Stacey M Cornelson, Ashley N Ruff, Muriel Perillat, Norman W Kettne. Sonoelastography of the trunk and lower extremity muscles in a case of Duchenne muscular dystrophy. Journal of ultrasound. vol 24. issue 3. 2021-11-19. PMID:31256365. |
duchenne muscular dystrophy (dmd) is a rare genetic disorder typically presenting with muscle weakness and reduced tone of trunk and lower extremities. |
2021-11-19 |
2023-08-13 |
Not clear |
| Fernanda Fortunato, Marianna Farnè, Alessandra Ferlin. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscular disorders : NMD. vol 31. issue 10. 2021-11-16. PMID:34736624. |
duchenne muscular dystrophy (dmd) is a severe x-linked disease characterized by progressive muscle weakness. |
2021-11-16 |
2023-08-13 |
Not clear |
| Paulo S Pedrazzani, Tatiana O P Araújo, Emilly Sigoli, Isabella R da Silva, Daiane Leite da Roza, Deise Lucia Chesca, Dilson E Rassier, Anabelle S Cornachion. Twenty-one days of low-intensity eccentric training improve morphological characteristics and function of soleus muscles of mdx mice. Scientific reports. vol 11. issue 1. 2021-11-15. PMID:33574358. |
duchene muscular dystrophy (dmd) is caused by the absence of the protein dystrophin, which leads to muscle weakness, progressive degeneration, and eventually death due to respiratory failure. |
2021-11-15 |
2023-08-13 |
mouse |
| Arun Shastry, Sankaramoorthy Aravind, Meeta Sunil, Keerthi Ramesh, Berty Ashley, Nithyanandan T, Vedam L Ramprasad, Ravi Gupta, Somasekar Seshagiri, Upendra Nongthomba, Sameer Phalk. Matrilineal analysis of mutations in the DMD gene in a multigenerational South Indian cohort using DMD gene panel sequencing. Molecular genetics & genomic medicine. vol 9. issue 5. 2021-10-29. PMID:33960727. |
duchenne muscular dystrophy (dmd) is an x-linked recessive neuromuscular disorder characterised by progressive irreversible muscle weakness, primarily of the skeletal and the cardiac muscles. |
2021-10-29 |
2023-08-13 |
Not clear |